Cargando…
The Use of Metformin and the Incidence of Lung Cancer in Patients With Type 2 Diabetes
OBJECTIVE: Observational studies have associated metformin use with a decreased risk of lung cancer incidence in patients with type 2 diabetes, but the studies had important methodological shortcomings. The objective of this study was to determine whether metformin use is associated with a decreased...
Autores principales: | Smiechowski, Brielan B., Azoulay, Laurent, Yin, Hui, Pollak, Michael N., Suissa, Samy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526233/ https://www.ncbi.nlm.nih.gov/pubmed/22923670 http://dx.doi.org/10.2337/dc12-0740 |
Ejemplares similares
-
Response to Comment on: Smiechowski et al. The Use of Metformin and the Incidence of Lung Cancer in Patients With Type 2 Diabetes. Diabetes Care 2013;36:124–129
por: Suissa, Samy, et al.
Publicado: (2013) -
Metformin and the Risk of Cancer: Time-related biases in observational studies
por: Suissa, Samy, et al.
Publicado: (2012) -
Response to Yang and Chan. Metformin and the Risk of Cancer: Time-Related Biases in Observational Studies. Diabetes Care 2012;35:2665–2673
por: Suissa, Samy, et al.
Publicado: (2013) -
Response to Bodmer et al. Metformin and the Risk of Cancer: Time-Related Biases in Observational Studies. Diabetes Care 2012;35:2665–2673
por: Suissa, Samy, et al.
Publicado: (2013) -
The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study
por: Azoulay, Laurent, et al.
Publicado: (2012)